title: Inhibition of cAMP-dependent protein kinase plays a key role in the induction of mitosis and nuclear envelope breakdown in mammalian cells.
abstract: Inhibiting cAMP-dependent protein kinase (A-kinase) in mammalian fibroblasts through microinjection of a modified specific inhibitor peptide, PKi(m) or the purified inhibitor protein, PKI, resulted in rapid and pronounced chromatin condensation at all phases of the cell cycle. Together with these changes in chromatin, a marked reorganization of microtubule network occurred, accompanied in G2 cells by extensive alterations in cell shape which have many similarities to the premitotic phenotype previously observed after activation of p34cdc2 kinase, including the lack of spindle formation and the persistence of a nuclear envelope. In order to examine whether A-kinase inhibition and p34cdc2 kinase form part of the same or different inductive pathways, PKI and p34cdc2 kinase were injected together. Co-injection of both components resulted in nuclear envelope disassembly, an event not observed with injection of either component alone. This result implies that p34cdc2 and A-kinase inhibition have complementary and additive effects on the process of nuclear envelope breakdown in living fibroblasts, a conclusion further supported by our observation of a pronounced dephosphorylation of lamins A and C in cells after injection of PKi(m). Taken together, these data suggest that down-regulation of A-kinase is a distinct and essential event in the induction of mammalian cell mitosis which co-operates with the p34cdc2 pathway.
authors.affiliation: Cell Biology Unit, CRBM, CNRS-INSERM, Montpellier, France.
authors.forename: N J
authors.initials: NJ
authors.lastname: Lamb
authors.forename: J C
authors.initials: JC
authors.lastname: Cavadore
authors.forename: J C
authors.initials: JC
authors.lastname: Labbe
authors.forename: R A
authors.initials: RA
authors.lastname: Maurer
authors.forename: A
authors.initials: A
authors.lastname: Fernandez
mesh_terms: D000818:Animals; D016203:CDC2 Protein Kinase / Q000494:pharmacology; D002453:Cell Cycle; D002478:Cells, Cultured; D002843:Chromatin / Q000648:ultrastructure; D066298:In Vitro Techniques; D034882:Lamins; D008845:Microinjections; D008870:Microtubules / Q000648:ultrastructure; D008938:Mitosis / Q000187:drug effects; D009685:Nuclear Envelope / Q000502:physiology*; D009687:Nuclear Proteins / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors; D051381:Rats; D008941:Spindle Apparatus / Q000648:ultrastructure; D013997:Time Factors
chemical_list: D002843:Chromatin; D034882:Lamins; D009687:Nuclear Proteins; D010455:Peptides; D047428:Protein Kinase Inhibitors; D016203:CDC2 Protein Kinase